Primary Job Title Managing Director Primary Organization MPM Capital
Location Cambridge, Massachusetts, United States Regions Greater Boston Area, East Coast, New England Gender Male Also Known As Daniel Hicklin
Investor Type
Dan Hicklin, Ph.D., joined MPM in 2014 subsequent to his successful role as President & Chief Scientific Officer and member of the Board of CoStim Pharmaceuticals (acquired by Novartis:NVS). He now serves as President and CEO of Potenza Therapeutics, an immuno-oncology company founded by MPM. Dan is also a board member of Tizona Therapeutics
and Harpoon Therapeutics, two MPM portfolio companies.
